A haplotype of the human CXCR1 gene protective against rapid disease progression in HIV-1+ patients

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 9, 2007, Pages 3354-3359

  Vasilescu, A ^a,b   Terashima, Y ^c,d   Enomoto, M ^c,d   Heath, S ^a   Poonpiriya, V ^c   Gatanaga, H ^e   Do, H ^a,b   Diop, G ^a,b   Hirtzig, T ^a,b   Auewarakul, P ^f   Lauhakirti, D ^f   Sura, T ^g   Charneau, P ^h   Marullo, S ⁱ   Therwath, A ^b,j   Oka, S ^e   Kanegasaki, S ^d   Lathrop, M ^a   Matsushima, K ^c   Zagury, J F ^b,l   Matsuda, F ^a,k   more..

^a CENTRE NATIONAL DE GÉNOTYPAGE   (France)

^b INSERM   (France)

^c UNIVERSITY OF TOKYO   (Japan)

^d Effector Cell Institute Inc   (Japan)

^e NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^f MAHIDOL UNIVERSITY   (Thailand)

^g MAHIDOL UNIVERSITY   (Thailand)

^h INSTITUT PASTEUR   (France)

ⁱ INSTITUT COCHIN   (France)

^j UNIVERSITÉ PARIS DESCARTES   (France)

^k KYOTO UNIVERSITY   (Japan)

^l Bioinformatique et Chimie Moléculaire   (France)

more..

Author keywords

AIDS; Chemokine receptor; Genotyping; SNP

Indexed keywords

ARGININE; CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; COMPLEMENTARY DNA; CYSTEINE; INTERLEUKIN 8; METHIONINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; AMINO TERMINAL SEQUENCE; ANTIGEN EXPRESSION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DISEASE COURSE; GENETIC TRANSFECTION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKEMIA CELL LINE; OSTEOSARCOMA CELL; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIGENS, CD4; BLOTTING, WESTERN; CELL LINE, TUMOR; DISEASE PROGRESSION; FLOW CYTOMETRY; GENE COMPONENTS; GENE EXPRESSION REGULATION; GENE FREQUENCY; HAPLOTYPES; HIV-1; HUMANS; IMMUNOHISTOCHEMISTRY; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CXCR4; RECEPTORS, INTERLEUKIN-8A; VARIATION (GENETICS);

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33847649978     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0611670104     Document Type: Article

References (30)

1. McCune JM (2001) Nature 410:974-979.
2. Taylor JM, Tan SJ, Detels R, Giorgi 3V (1991) AIDS 5:159-167.
3. Haynes BF, Pantaleo G, Fauci AS (1996) Science 271:324-328.
4. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P (1995) Science 270:1811-1815.
5. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, et al. (1996) Nature 381:661-666.
6. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, Paxton WA (1996) Nature 381:667-673.
7. Feng Y, Broder CC, Kennedy PE, Berger EA (1996) Science 272:872-877.
8. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, Saragosti S, Lapoumeroulie C, Cognaux J, Forceille C, et al. (1996) Nature 382:722-725.
9. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, Goedert JJ, Buchbinder SP, Vittinghoff E, Gomperts E, et al. (1996) Science 273:1856-1862.
10. Liu R, Paxton WA Choe S, Ceradini D, Martin SR, Horuk R, MacDonald ME, Stuhlmann H, Koup RA, Landau NR (1996) Cell 86:367-377.
11. Baggiolini M, Dewald B, Moser B (1997) Annu Rev Immunol 15:675-705.
12. Schroder JM, Mrowietz U, Morita E, Christophers E (1987) J Immunol 139:3474-3483.
13. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, Oppenheim JJ, Leonard EJ (1987) Proc Natl Acad Sci USA 84:9233-9237.
14. Larsen CG, Anderson AO, Appella E, Oppenheim JJ, Matsushima K (1989) Science 243:1464-1466.
15. Matsumoto T, Miike T, Nelson RP, Tradeau WL, Lockey RF, Yodoi J (1993) Clin Exp immunol 93:149-151.
16. Meddows-Taylor S, Martin DJ, Tiemessen CT (1999) Clin Diagn Lab Immunol 6:345-351.
17. Meddows-Taylor S, Martin DJ, Tiemessen CT (1998) J Infect Dis 177:921-930.
18. Lane BR, Lore K, Bock PJ, Andersson J, Coffey MJ, Strieter RM, Markovitz DM (2001) J Virol 75:8195-8202.
19. Richardson RM, Tokunaga K, Marjoram R, Sata T, Snyderman R (2003) J Biol Chem 278:15867-15873.
20. Qanbar R, Bouvier M (2003) Pharmacol Ther 97:1-33.
21. Leong SR, Kabakoff RC, Hebert CA (1994) J Biol Chem 269:19343-19348.
22. Hendel H, Cho YY, Gauthier N, Rappaport J, Schachter F, Zagury JF (1996) Biomed Pharmacother 50:480-487.
23. Rappaport J, Cho YY, Hendel H, Schwartz FJ, Schachter F, Zagury JF (1997) Lancet 349:922-923.
24. Lin YL, Mettling C, Portales P, Reynes J, Clot J, Corbeau P (2002) Proc Natl Acad Sci USA 99:15590-15595.
25. Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR (1997) J Exp Med 185:621-628.
26. Lee S, Lapham CK, Chen H, King L, Manischewitz J, Romantseva T, Mostowski H, Stantchev TS, Broder CC, Golding H (2000) J Virol 74:5016-5023.
27. Blanpain C, Wittamer V, Vanderwinden JM, Boom A, Renneboog B, Lee B, Le Poul E, El Asmar L, Govaerts C, Vassart G, et al. (2001) J Biol Chem 276:23795-23804.
28. Stemmler S, Arinir U, Klein W, Rohde G, Hoffjan S, Wirkus N, Reinitz-Rademacher K, Bufe A, Schultze-Werninghaus G, Epplen JT (2006) Genes Immun 6:225-230.
29. Kauffmann F, Dizier MH, Pin I, Paty E, Gormand F, Vervloet D, Bousquet J, Neukirch F, Annesi I, Oryszczyn MP, et al. (1997) Am J Respir Crit Care Med 156:S123-S129.
30. Takahashi M, Matsuda F, Margetic N, Lathrop M (2003) J Bioinform Comput Biol 1:253-265.